• Data
    • Overview
    • Clinical notes
    • Images
    • Mother-child
    • Oncology
    • Regulatory grade
    • Truveta Language Model
    • Truveta Studio
  • Genomics
  • Solutions
    • Life science
    • Public health
    • Healthcare
  • Research
  • Resources
  • About
    • Blog
    • Members
    • Leadership
    • Events & webinars
    • Newsroom
    • Careers
Get started
Sign in
LinkedIn Live: Truveta Research discusses recent maternal heart health study

LinkedIn Live: Truveta Research discusses recent maternal heart health study

by Truveta staff | Feb 15, 2023 | News, Research

The United States is one of the most dangerous high-income countries in which to give birth. Nearly every negative maternal health outcome impacts women of color more than white women. This February, in honor of Heart Health Month and Black History Month, Truveta...
From questions to answers: How Truveta Studio was used to create rapid heart health equity insights in just a few weeks

From questions to answers: How Truveta Studio was used to create rapid heart health equity insights in just a few weeks

by Truveta staff | Feb 14, 2023 | Technology

It’s no secret — yet surprising and tragic — that the United States is one of the most dangerous high-income countries in which to give birth. It’s also unfortunately well known that nearly every maternal health outcome in the United States negatively affects women of...
Preeclampsia-related heart failure disproportionately impacts Black mothers

Preeclampsia-related heart failure disproportionately impacts Black mothers

by Truveta Research | Feb 7, 2023 | Research, Research Insights

Among women with preeclampsia, new Truveta Research findings show that Black women are two times more likely to experience heart failure than white women.  Maternal health outcomes in the US are worse than in many other high-income countries such as England, France,...

Share this


Recent posts

  • Truveta leads a new era in cancer research with the most complete, representative, and timely real-world data on all cancers
  • Top 5 takeaways from Truveta Symposium 2025
  • Women’s health: Pain medication remains rare for women receiving IUDs

Follow Truveta


Sign up for our newsletter

Ready to accelerate your research with representative, complete, and timely real-world data?

Get started

Truveta Data

Truveta Genome Project

Solutions

Research

Resources

Blog

Newsroom

Careers

Privacy notice

Contact us

© Truveta 2025

Interested in learning more?

Our website uses cookies to ensure you have the best experience.AcceptPrivacy notice